Two lists worth a look: Promising life sciences start-ups and powerful VC firms
The VC list is here, in PDF form. The run-down:
1 Polaris Venture Partners
2 Atlas Venture
3 MPM Capital
4 Novartis Corp.
5 SV Life Sciences Advisers
6 Flagship Ventures
7 TVM Capital
8 Boston University Community Technology Fund
9 Oxford Bioscience Partners
10 HealthCare Ventures
And the list of companies is here, in PDF form. The first company on the list, Adnexus Therapeutics, just filed for an IPO today. That list, in alphabetical order:
Adnexus Therapeutics (MA, just filed to go public)
Aveo Pharmaceuticals (MA)
Codon Devices (MA)
Helicos BioSciences (MA, now public)
Microbia (MA)
Neurotech (RI)
Radius Health (MA)
Sirtris Pharmaceuticals (MA, now public)
Targanta Therapeutics (MA)
Tetraphase Pharmaceuticals (MA)
Plus three companies Dickman dubbed worthy of being "on the radar": Acceleron Pharma, GI Dynamics, and Tempo Pharmaceuticals.
Labels: Adnexus Therapeutics, Aveo, Codon Devices, Helicos, Microbia, Neurotech, Polaris Venture Partners, Sirtris Pharma, start-ups, Targanta, Tempo, Tetraphase, venture capital